Lyell Immunopharma, Inc.
USD14.89
-2.26 (-13.18%)
CEO
Lynn Seely
IPO Date
2021-06-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$17.15
Prev. Close
$17.15
Day Low
$14.71
Day High
$17.16
52W Low
$7.78
52W High
$45.00
Market Cap
$0.35B
Volume
0.12M
| $0.00 |
| 9 Mar 2026 | ARCH Venture Partners IX, LLC | 10 percent owner | P-Purchase | Acquired | 488,090 | $25.61 |
| 9 Mar 2026 | ARCH Venture Fund XIII, L.P. | 10 percent owner | P-Purchase | Acquired | 488,090 | $25.61 |
| 12 Feb 2026 | Seely Lynn | director, officer: President and CEO | S-Sale | Disposed | 7,455 | $23.39 |
| 12 Feb 2026 | Hill Stephen J. | Chief Operating Officer | S-Sale | Disposed | 1,236 | $23.39 |
| 12 Feb 2026 | Lee Gary K. | Chief Scientific Officer | S-Sale | Disposed | 1,671 | $23.39 |
| 11 Feb 2026 | Hill Stephen J. | Chief Operating Officer | S-Sale | Disposed | 109 | $23.12 |
| 11 Feb 2026 | Hill Stephen J. | Chief Operating Officer | A-Award | Acquired | 65,000 | $23.71 |
| 11 Feb 2026 | Hill Stephen J. | Chief Operating Officer | A-Award | Acquired | 4,000 | $0.00 |